223 related articles for article (PubMed ID: 38667326)
21. Cancer-associated fibroblasts regulate keratinocyte cell-cell adhesion via TGF-β-dependent pathways in genotype-specific oral cancer.
Cirillo N; Hassona Y; Celentano A; Lim KP; Manchella S; Parkinson EK; Prime SS
Carcinogenesis; 2017 Jan; 38(1):76-85. PubMed ID: 27803052
[TBL] [Abstract][Full Text] [Related]
22. miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes.
Hung PS; Tu HF; Kao SY; Yang CC; Liu CJ; Huang TY; Chang KW; Lin SC
Carcinogenesis; 2014 May; 35(5):1162-71. PubMed ID: 24480806
[TBL] [Abstract][Full Text] [Related]
23. Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability.
Piboonniyom SO; Duensing S; Swilling NW; Hasskarl J; Hinds PW; Münger K
Cancer Res; 2003 Jan; 63(2):476-83. PubMed ID: 12543805
[TBL] [Abstract][Full Text] [Related]
24. Expression of apoptotic signaling proteins in leukoplakia and oral lichen planus: quantitative and topographical studies.
Tanda N; Mori S; Saito K; Ikawa K; Sakamoto S
J Oral Pathol Med; 2000 Sep; 29(8):385-93. PubMed ID: 10972347
[TBL] [Abstract][Full Text] [Related]
25. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
26. Expression of telomerase components in oral keratinocytes and squamous cell carcinomas.
Fujimoto R; Kamata N; Yokoyama K; Ueda N; Satomura K; Hayashi E; Nagayama M
Oral Oncol; 2001 Feb; 37(2):132-40. PubMed ID: 11167139
[TBL] [Abstract][Full Text] [Related]
27. [Exploration of tumor suppressors p16INK4a and p14ARF in oral leukoplakias].
Nitsche M; Koy S; Mörz M; Koch R; Eckelt U
Mund Kiefer Gesichtschir; 2007 Dec; 11(6):317-26. PubMed ID: 17990010
[TBL] [Abstract][Full Text] [Related]
28. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics.
Dickson MA; Hahn WC; Ino Y; Ronfard V; Wu JY; Weinberg RA; Louis DN; Li FP; Rheinwald JG
Mol Cell Biol; 2000 Feb; 20(4):1436-47. PubMed ID: 10648628
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
30. p53 expression in oral precancer as a marker for malignant potential.
Murti PR; Warnakulasuriya KA; Johnson NW; Bhonsle RB; Gupta PC; Daftary DK; Mehta FS
J Oral Pathol Med; 1998 May; 27(5):191-6. PubMed ID: 9682980
[TBL] [Abstract][Full Text] [Related]
31. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
Gao Y; Guo ZL; Luo HY; Wang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
[TBL] [Abstract][Full Text] [Related]
33. E-cadherin downregulation and Twist overexpression since early stages of oral carcinogenesis.
de Freitas Silva BS; Yamamoto-Silva FP; Pontes HA; Pinto Júnior Ddos S
J Oral Pathol Med; 2014 Feb; 43(2):125-31. PubMed ID: 23772858
[TBL] [Abstract][Full Text] [Related]
34. DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed non-malignant phenotype.
Chang SE; Foster S; Betts D; Marnock WE
Int J Cancer; 1992 Dec; 52(6):896-902. PubMed ID: 1459732
[TBL] [Abstract][Full Text] [Related]
35. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
[TBL] [Abstract][Full Text] [Related]
36. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions.
Warnakulasuriya KA; Johnson NW
J Oral Pathol Med; 1992 Oct; 21(9):404-8. PubMed ID: 1432735
[TBL] [Abstract][Full Text] [Related]
37. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
[TBL] [Abstract][Full Text] [Related]
38. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH
Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687
[TBL] [Abstract][Full Text] [Related]
39. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway.
Liu W; Yao Y; Shi L; Tang G; Wu L
J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929
[TBL] [Abstract][Full Text] [Related]
40. Short telomeres in an oral precancerous lesion: Q-FISH analysis of leukoplakia.
Aida J; Kobayashi T; Saku T; Yamaguchi M; Shimomura N; Nakamura K; Ishikawa N; Maruyama S; Cheng J; Poon SS; Sawabe M; Arai T; Takubo K
J Oral Pathol Med; 2012 May; 41(5):372-8. PubMed ID: 22122732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
